Search

everythinglearnresearchcommunity

for

Search:↓

Leucine levels may affect hair loss after bariatric surgery.

Minoxidil can temporarily increase hair shedding, causing anxiety and treatment discontinuation.

First-time mothers had higher stress hormone levels in late pregnancy than mothers who had given birth before.

Male pattern baldness may predict prostate cancer risk.

COVID-19 can cause or worsen skin conditions and might show early signs of infection.

PRP injections did not significantly improve ovarian function in women with low ovarian reserve.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Taking finasteride every other month can still help with hair loss but may be less effective over time compared to taking it daily.

Androgenic alopecia in men is mainly linked to family history, hormonal imbalances, and metabolic issues, but can also be influenced by lifestyle habits, environmental factors, and deficiencies in certain vitamins and microelements like copper.

PRP injections are a simple, safe, and cost-effective treatment for hair loss.

Vietnamese women with PCOS tend to be younger, have larger waists, higher AMH levels, and more body hair than those without PCOS.

Tumescent liposuction reduces waist and hip size but doesn't significantly change metabolic markers, though it may slightly improve blood pressure and certain protein levels.

Skin changes were less common, and photo assessments were unreliable.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

PCOS may be linked to spina bifida in young females.

Long-COVID symptoms can last more than a year and change over time.

Hydroxychloroquine may help delay skin damage in lupus patients.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Women with lichen planopilaris and frontal fibrosing alopecia often have other health issues like hypothyroidism and lupus.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

Nanofat injections can significantly improve hair growth in men with hair loss for up to a year.